Document:

Exhibit
10.1

 

BESPOKE EXTRACTS,
INC.

Securities

PURCHASE AGREEMENT

 

This Securities Purchase Agreement (the “Agreement”)
is made as of the ____ day of December 2021 by and between BESPOKE EXTRACTS, INC.., a Nevada corporation (the “Company”)
and the Purchasers identified on the signature pages hereto (each a “Purchaser” and together the “Purchasers”).

 

RECITALS

 

The Company desires to issue and sell, and each
Purchaser desires to purchase, the number of shares (the “Shares”) of the Company’s common stock, par value $0.001
per share (the “Common Stock”), set forth for such Purchaser on the signature pages hereto, and warrants to purchase shares
of the Company’s Common Stock (the “Warrants”), in substantially the form attached to this Agreement as Exhibit
A. The Shares, the Warrants and the shares of Common Stock issuable upon exercise thereof are collectively referred to
herein as the “Securities.” The Company is proposing to issue and sell (the “Offering”) up to 200,000,000
Units (as defined below).

 

AGREEMENT

 

In consideration of the mutual promises contained
herein and other good and valuable consideration, receipt of which is hereby acknowledged, the parties to this Agreement agree as follows:

 

1. Purchase
and Sale of Common Stock and Warrants.

 

(a) Subject
to the terms and conditions of this Agreement, each Purchaser agrees to purchase at the Closing (as defined below) and the Company agrees
to sell and issue to each Purchaser (i) the number of Shares set forth for such Purchaser on the signature pages hereto and (ii) the number
of Warrants set forth for such Purchase on the signature pages hereto, exercisable for a period of one year for the number of shares of
Common Stock equal to 25% of the Common Stock purchased by such Purchaser pursuant to clause (i) above, at a per share exercise price
equal to $0.05 per share. Each Warrant shall be exercisable for a period of one (1) year after the Closing. The purchase price of each
share of Common Stock purchased by a Purchaser together with a Warrant, each entitling the Purchaser to purchase shares of Common Stock
in an amount equal to 25% of the Common Stock purchased (together, a “Unit”) shall be $0.005 per Unit. The total purchase
price payable by each Purchaser shall be the amount set forth for such Purchaser on the signature pages hereto. The Company’s agreements
with each of the Purchasers are separate agreements, and the sales of the Common Stock and Warrants to each of the Purchasers are separate
sales.

 

    1

     

    

 

2. Closing;
Delivery.

 

(a) The purchase
and sale of the Shares and Warrants shall take place remotely via the exchange of documents and signatures, or at such other
place as the Company and the Purchasers mutually agree upon, orally or in writing, as soon as practicable following such time that the
Purchasers have agreed to purchase at such closing an aggregate amount of Units equal to at least $250,000 (which time and
place are designated as the “Initial Closing”). The Initial Closing shall occur by December 30, 2021 unless extended
for a period of up to 30 days at the Company’s discretion. Officers and directors of the Company and their affiliates may purchase
securities in the Offering. In the event there is more than one closing, the term “Closing” shall apply to each such closing,
unless otherwise specified herein.

 

(i) At
each Closing, the Company shall deliver to each Purchaser Common Stock and Warrants to be purchased by such Purchaser against (A) payment
of the purchase price therefor by check payable to the Company, by wire transfer to a bank designated by the Company, cancellation of
indebtedness, or any combination thereof and (B) delivery of counterpart signature pages to this Agreement, provided that, the Company
will deliver the stock certificates for the Common Stock and the Warrants within 5 business days of the closing for such shares and Warrants.
In the event that payment by a Purchaser is made, in whole or in part, by cancellation of indebtedness, then such Purchaser shall surrender
to the Company for cancellation at such Closing any evidence of such indebtedness or shall execute an instrument of cancellation in form
and substance acceptable to the Company.

 

(ii) Until
such time as the aggregate proceeds from the Offering equal a total of one million dollars ($1,000,000.00), the Company may sell additional
Units to such persons or entities as determined by the Company, or to any Purchaser who desires to acquire additional Units, until the
termination date of the Offering of January 31, 2022 subject to the right of the Company to extend or terminate the Offering in its discretion.
All such sales shall be made on the terms and conditions set forth in this Agreement. The Company, in its sole discretion, shall determine
the time and place of each Closing subsequent to the Initial Closing. For purposes of this Agreement, and all other agreements contemplated
hereby, any additional purchaser so acquiring Units shall be deemed to be a “Purchaser” for purposes of this Agreement, and
any shares of common stock and warrants so acquired by such additional purchaser shall be deemed to be “Common Stock,” “Warrants”
and “Securities,” as applicable.

 

3. Representations
and Warranties of the Company. The Company hereby represents and warrants to each Purchaser that, as of the date hereof:

 

(a) Organization,
Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the
laws of the State of Nevada and has all requisite corporate power and authority to carry on its business as described in the Company’s
public filings with the Securities and Exchange Commission (the “Commission”). The Company is duly qualified to transact
business and is in good standing in each jurisdiction in which the failure so to qualify would have a material adverse effect on its business
or properties.

 

(b) Capitalization.
The authorized and issued and outstanding capital of the Company consists, or will consist immediately prior to the Initial Closing, of

 

    2

     

    

 

(i) Stock
Authorized and Outstanding 3,000,000,000 shares of Common Stock, par value $0.001 authorized, of which 318,839,621 shares are issued
and outstanding, and 50,000,000 shares of preferred stock, par value $0.001 authorized, of which 1,000 shares are designated Series A
Preferred Stock, none of which are issued and outstanding, and 1 share of Series C Preferred Stock is designated, issued and outstanding,
and which provides the holder thereof with 51% of the voting power of the Company’s stockholders.

 

(ii) Other
Rights. Except as disclosed in filings by the Company with the Securities and Exchange Commission since September 1, 2020 (the “SEC
Reports”), and except for options issued to officers, employees and consultants of the Company, there are no options or warrants
for the purchase from the Company of shares of Common Stock.  The Company is not a party or subject to any agreement or understanding,
and, to the Company’s knowledge, there is no agreement or understanding between any persons and/or entities, which affects or relates
to the voting or giving of written consents with respect to any security or by a director of the Company.

 

(c) Authorization.
All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization, execution and
delivery of this Agreement, the performance of all obligations of the Company hereunder, and the authorization, issuance (or reservation
for issuance), sale and delivery of the Common Stock and Warrants being sold hereunder and the Common Stock issuable upon exercise of
the Warrants has been taken or will be taken prior to the Initial Closing. This Agreement and the Warrants, when executed and delivered
by the Company, shall constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with
their respective terms except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and other
laws of general application affecting enforcement of creditors’ rights generally, and as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies.

 

(d) Valid
Issuance of Common Stock and Warrant Shares. The shares of Common Stock that are being purchased by the Purchasers hereunder,
when issued, sold and delivered in accordance with the terms of this Agreement for the consideration expressed herein, will be duly and
validly issued, fully paid, and nonassessable, and will be free of restrictions on transfer other than restrictions on transfer under
this Agreement and under applicable state and federal securities laws or liens or encumbrances created by or imposed by a Purchaser. The
Common Stock issuable upon exercise of the Warrants purchased hereunder has been duly and validly reserved for issuance and, upon issuance
in accordance with the terms of the Warrant, will be duly and validly issued, fully paid, and nonassessable and will be free of restrictions
on transfer other than restrictions on transfer under this Agreement and under applicable state and federal securities laws or liens or
encumbrances created by or imposed by a Purchaser.

 

(e) Effect
of Agreement. The execution, delivery and performance by the Company of this Agreement and the Warrants, will not violate the
charter documents, bylaws or formation documents of the Company or any law to which the Company is subject, or any judgment, award or
decree or any material indenture, material agreement or other material instrument to which the Company is a party, or by which the Company
or its properties or assets are bound, or conflict with, result in a breach of or constitute (with due notice or lapse of time or both)
a default under, any such indenture, agreement or other instrument, or result in the creation or imposition of any lien of any nature
whatsoever upon any of the properties or assets of the Company, except to the extent the effect thereof will not be materially adverse
to the Company’s ability to fulfill its obligations under this Agreement and the Warrants.

 

    3

     

    

 

(f) Legal
Proceedings. There is no order or action pending, or, to the knowledge of the Company, threatened against or affecting the Company
in connection with the Company’s performance hereunder. There is no matter as to which the Company, or, to the knowledge of the
Company, any affiliate of the Company has received any notice, claim or assertion which otherwise has been threatened against or affecting
the Company in connection with its performance hereunder.

 

4. Covenants
of the Company and the Purchasers.

 

(a) The
Company agrees to use its best efforts to file with the Commission as soon as reasonably practicable following the final closing under
this Agreement a registration statement on Form S-1 or such other form under the Securities Act then available to the Company (the “Registration
Statement”) providing for the resale of the shares of Common Stock purchased hereunder, including any shares of Common Stock
issuable upon exercise of the Warrants (collectively, the “Registrable Securities”). The Company shall use its commercially
reasonable efforts to cause such Registration Statement to be declared effective by the Commission as soon as practicable after the initial
filing thereof. Any Registration Statement shall provide for the resale from time to time, and pursuant to any method or combination of
methods legally available by the Purchasers of any and all Registrable Securities. The Company shall use its commercially reasonable efforts
to maintain the effectiveness of the Registration Statement until such time as the Common Stock sold hereunder may be sold under Rule
144 under the Securities Act; provided, however, that failure to do so shall not constitute a breach under this Section 4.

 

(b) The
Company shall pay all registration expenses in connection with the registration of the Registrable Securities pursuant to this Agreement.
Each Purchaser participating in a registration pursuant to this Section 4 shall bear such Purchaser’s proportionate share (based
on the total number of Registrable Shares sold in such registration) of all discounts and commissions payable to underwriters or brokers
and all transfer taxes and transfer fees in connection with a registration of Registrable Securities pursuant to this Agreement.

 

(c) It
shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 4 with respect to Registrable
Securities of any selling Purchaser that such selling Purchaser shall furnish to the Company such information as reasonably requested
by the Company to effect the registration of such Purchaser’s Registrable Securities, including information regarding such selling
Purchaser, the Registrable Securities held by it, and the intended method of disposition, as well as in connection with any sale of Registrable
Securities by the Purchasers.

 

(d) The Company shall use the proceeds from the
offering for general corporate purposes, including working capital.

 

5. Representations
and Warranties of the Purchasers. Each Purchaser hereby represents and warrants to the Company that:

 

(a) Authorization.
Such Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Purchaser,
will constitute a valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms,
except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general
application affecting enforcement of creditors’ rights generally, and as limited by laws relating to the availability of a specific
performance, injunctive relief, or other equitable remedies.

 

    4

     

    

 

(b) Purchase
Entirely for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the
Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired
by the Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view
to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation
in, or otherwise distributing the same. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently
have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participations to such person or to
any third person, with respect to any of the Securities. The Purchaser has not been formed for the specific purpose of acquiring any of
the Securities.

 

(c) Knowledge.
The Purchaser is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the
Company to reach an informed and knowledgeable decision to acquire the Securities. The Purchaser understands that an investment in the
Company involves a high degree of risk, including the possible loss of the Purchaser’s entire investment and the risks set forth
in the SEC Reports. The Purchaser has had the opportunity to review the SEC Reports. The Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. The Purchaser has been
afforded (a) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the
Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities
and (b) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or
expense that is necessary to make an informed investment decision with respect to the investment.

 

(d) Restricted
Securities. Purchaser understands that the Securities have not been registered under the Securities Act by reason of a specific
exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment
intent and the accuracy of the Purchaser’s representations as expressed herein. The Purchaser understands that the Securities are
“restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser
must hold the Securities indefinitely unless they are registered with the Commission and qualified by state authorities,
or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that the Company’s
obligation to register or qualify the Securities for resale is limited to the registration rights provided to Purchasers pursuant to this
Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned
on various requirements including, but not limited to, the time and manner of sale, the holding period for the Securities, and on requirements
relating to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation and may not be
able to satisfy.

 

    5

     

    

 

(e) No
Public Market. The Purchaser understands that there is no public market now for Warrants and only a limited market exists for
the Company’s Common Stock and the Company has made no assurances that a significant public market will ever exist for the Warrants.

 

(f) Legends.
The Purchaser understands that the Securities, and any securities issued in respect thereof or exchange therefor, may bear one or all
of the following or substantially similar legends:

 

(i) “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT
AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”

 

(ii) Any
legend required by the Blue Sky laws of any state to the extent such laws are applicable to the shares represented by the certificate
so legended.

 

(g) Accredited
Investor. The Purchaser (i) has such knowledge and experience in financial and business matters that Purchaser is capable of evaluating
the merits and risks of the prospective investment in the Securities, and either (ii) is an accredited investor as defined in Rule 501(a)
of Regulation D promulgated under the Securities Act and has accurately completed the accredited investor certification attached as Schedule
A, or (iii) if Purchaser is not an accredited investor, Purchaser has accurately completed the non-accredited investor acknowledgement
form attached as Schedule B.

 

(h) Purchaser has been provided
a copy of the Company’s annual report on Form 10-K for the year ended August 31, 2021 filed with the Commission on December 13,
2021, the Company’s Form 8-K filed with the Commission on December 15, 2021, and any other reports filed by the Company with the
Commission since such filing of the Form 10-K.

 

6. Conditions
of the Purchasers’ Obligations at Closing. The obligations of each Purchaser to the Company under this Agreement are subject
to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived:

 

(a) Representations,
Warranties and Covenants. The representations and warranties of the Company contained in Section 3 (including those incorporated
by reference) shall be true on and as of the Closing with the same effect as though such representations and warranties had been made
on and as of the date of the Closing and the Company shall have complied with all covenants in this Agreement as of or prior to the Closing.

 

(b) Qualifications.
All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state
that are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be obtained and effective
as of the Closing.

 

    6

     

    

 

7. Conditions
of the Company’s Obligations at Closing. The obligations of the Company to each Purchaser under this Agreement are subject
to the fulfillment, on or before the Closing, of each of the following conditions, unless otherwise waived (it being acknowledged that
the Company may accept or reject any subscription for Securities in its sole discretion):

 

(a) Representations,
Warranties and Covenants. The representations and warranties of each Purchaser contained in Section 4 shall be true on and as
of the Closing with the same effect as though such representations and warranties had been made on and as of the Closing and the Purchaser
shall have complied with all covenants in this Agreement as of or prior to the Closing.

 

(b) Payment
of Purchase Price. The Purchaser shall have delivered the purchase price specified in Section 1 for the number of shares of Common
Stock and Warrants to purchase shares of Common Stock set forth for such Purchaser on the signature pages hereto..

 

(c) Qualifications.
All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or of any state
that are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be obtained and effective
as of the Closing.

 

8. Miscellaneous
and Other Covenants.

 

(a) Successors
and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors
and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.

 

(b) Governing
Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be
governed, construed and interpreted in accordance with the laws of the State of New York without giving effect to principles of conflicts
of law. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated
by this Agreement and the Warrants shall be commenced exclusively in the state and federal courts sitting in the City of New York. If
either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action,
suit or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred
with the investigation, preparation and prosecution of such action or proceeding.

 

(c) Counterparts.
This Agreement may be executed in two or more counter-parts, each of which shall be deemed an original and all of which together shall
constitute one instrument.

 

(d) Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing
or interpreting this Agreement.

 

(e) Notices.
Any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient upon receipt, when delivered personally
or by courier, overnight delivery service or confirmed electronic mail or facsimile, or 48 hours after being deposited in the U.S. mail
as certified or registered mail with postage prepaid, if such notice is addressed to the party to be notified at such party’s address
or facsimile number as set forth below or as subsequently modified by written notice.

 

    7

     

    

 

(f) Finder’s
Fee. Each party represents that it neither is nor will be obligated for any finder’s fee or commission in connection with
this transaction. Each Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation
in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which
each Purchaser or any of its officers, employees, or representatives is responsible. The Company agrees to indemnify and hold harmless
each Purchaser from any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses
of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives
is responsible.

 

(g) Amendments
and Waivers. Any term of this Agreement may be amended or waived only with the written consent of the Company and the holders
of at least a majority of the Common Stock to be purchased hereunder. Any amendment or waiver effected in accordance with this Section
7(g) shall be binding upon each Purchaser and each transferee of the Securities, each future holder of all such Securities, and the Company.

 

(h) Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate
such provision in good faith, in order to maintain the economic position enjoyed by each party as close as possible to that under the
provision rendered unenforceable. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such
provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if
such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms.

 

(i) Entire
Agreement. This Agreement, the Warrants, and the Exhibits and Schedules hereto and the other documents referred to herein and
therein constitute the entire agreement between the parties hereto pertaining to the subject matter hereof, and any and all other written
or oral agreements existing between the parties hereto are expressly canceled.

 

(j) Exculpation
Among Purchasers. Each Purchaser acknowledges that it is not relying upon any other Purchaser, in making its investment or decision
to invest in the Company. Each Purchaser agrees that no Purchaser nor the respective controlling persons, officers, directors, partners,
agents, or employees of any Purchaser shall be liable for any action heretofore or hereafter taken or omitted to be taken by any of them
in connection with the Securities.

 

(k) Expenses.
Each of the Parties shall be responsible for their respective expenses and costs incurred in connection with the negotiation, documentation
and execution of this Agreement and the other agreements, and documents contemplated herein and therein.

 

    8

     

    

 

The parties have executed this Securities Purchase
Agreement as of the date first written above.

 

	 	COMPANY:
	 	 	 
	 	BESPOKE EXTRACTS, INC.
	 	 	 
	 	By:	                    
	 	 	 
	 	Address: 	2590 Walnut Street, Suite 4
	 	 	Denver, CO 80205

 

 

    9

     

    

 

[PURCHASER SIGNATURE PAGES TO BESPOKE EXTRACTS,
INC. SECURITIES PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.

 

Name of Purchaser: ______________________________________________________

 

Signature of Authorized Signatory of Purchaser:
_________________________________

 

Name of Authorized Signatory: _______________________________________________

 

Title of Authorized Signatory: ________________________________________________

 

Email Address of Authorized Signatory:_________________________________________

 

Facsimile Number of Authorized Signatory: __________________________________________

 

Address for Notice to Purchaser:

 

Address for Delivery of Securities to Purchaser (if not same as address
for notice):

 

Subscription Amount: $_________________

 

Number of Shares: _________________

 

Number of Warrants: __________________

 

EIN or SS Number: ____________________

 

    10

     

    

 

SCHEDULE A

 

BESPOKE EXTRACTS, INC.

 

ACCREDITED INVESTOR
CERTIFICATION

 

 

 

 

 

 

 

 

 

SCHEDULE A-1

     

     

    

 

Schedule B

 

Non-Accredited Investor Acknowledgement

  

 

 

 

 

 

 

 

 

 

SCHEDULE B-1

     

     

    

 

Exhibit A

 

Form of WarrantExhibit 10.2

 

Form of Warrant

 

NEITHER THIS WARRANT NOR THE SECURITIES FOR WHICH THIS WARRANT IS EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED
OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR
IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE
TO THE COMPANY.

 

	Warrant # 2021-____	Issue Date: December ___, 2021

 

BESPOKE EXTRACTS, INC.

 

WARRANT

 

TO PURCHASE SHARES OF COMMON STOCK

 

THIS WARRANT (the “Warrant”)
certifies that, for value received, ___________ (the “Holder”) is entitled, upon the terms and subject to the limitations
on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”)
and on or prior to the close of business of the twelfth (12th) month after the Initial Exercise Date (the “Expiration
Date”) but not thereafter, to subscribe for and purchase from Bespoke Extracts, Inc.., a Nevada corporation (the “Company”),
up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s $0.001 par
value common stock, (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal
to Five cents ($0.05) (the “Purchase Price”), subject to adjustment hereunder (the “Exercise Price”).

 

1. The Holder may exercise
this Warrant, in whole or in part, upon submission of the exercise form annexed hereto duly executed, by email or fax to the Company,
together with a certified or bank cashier’s check payable to the order of the Company or wire transfer of immediately payable funds, in
the amount of the Purchase Price multiplied by the number of shares of Common Stock being purchased. In the event the Warrant is exercised
in full, the Holder shall return promptly return the original Warrant to the Company following such exercise.

 

    1

     

    

 

2. “Principal Market”
shall include the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange,
or any tier of the OTC Markets (or any successors to any of the foregoing) (whichever is at the time the principal trading exchange or
market for the Common Stock), or any securities exchange or other securities market on which the Common Stock is then being listed, quoted
or traded. The Company will from time to time take all action which may be necessary so that the Warrant Shares, immediately upon their
issuance upon the exercise of the Warrant, will be listed on the Principal Market on which other shares of Common Stock are then listed,
if any.

 

3. The person or persons in
whose name or names any certificate representing Common Stock is issued hereunder shall be deemed to have become the holder of record
of the Common Stock represented thereby as of the close of business on the date on which this Warrant is exercised with respect to such
shares, whether or not the transfer books of the Company shall be closed. Until such time as this Warrant is exercised or terminates,
the Purchase Price payable and the number and character of securities issuable upon exercise of this Warrant are subject to adjustment
as hereinafter provided.

 

4. The Company covenants that
it will at all times reserve and keep available a number of its authorized Common Stock, free from all preemptive rights, which will be
sufficient to permit the exercise of this Warrant. The Company further covenants that such shares as may be issued pursuant to the exercise
of this Warrant will, upon issuance, be duly and validly issued, fully paid and nonassessable and free from all taxes, liens, and charges.
Unless previously exercised, this Warrant shall expire at 5:00 p.m. Eastern Standard Time, on the Expiration Date and shall be void thereafter
or can be extended at the Company’s discretion.

 

5. If the Company subdivides
its outstanding Common Stock, by split-up or otherwise, or combines its outstanding Common Stock, the Purchase Price then applicable to
shares covered by this Warrant shall forthwith be proportionately decreased in the case of a subdivision, or proportionately increased
in the case of a combination.

 

6. If (a) the Company reorganizes
its capital, reclassifies its capital stock, consolidates or merges with or into another corporation (but only if the Company is not the
surviving corporation and no longer has more than a single shareholder) or sells, transfers or otherwise disposes of all or substantially
all its property, assets, or business to another corporation, and (b) pursuant to the terms of such reorganization, reclassification,
merger, consolidation, or disposition of assets, shares of common stock of the successor or acquiring corporation, or any cash, shares
of stock, or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition
to or in lieu of common stock of the successor or acquiring corporation (“Other Property”), are to be received by or
distributed to the holders of Common Stock, then (c) Holder shall have the right thereafter to receive, upon exercise of this Warrant,
the same number of shares of common stock of the successor or acquiring corporation and Other Property receivable upon such reorganization,
reclassification, merger, consolidation, or disposition of assets as a holder of the number of Common Stock for which this Warrant is
exercisable immediately prior to such event. At the time of such reorganization, reclassification, merger, consolidation or disposition
of assets, the successor or acquiring corporation shall expressly assume the due and punctual observance and performance of each and every
covenant and condition of this Warrant to be performed and observed by the Company and all the obligations and liabilities hereunder,
subject to such modifications as may be deemed appropriate (as determined by resolution of the Board of Directors of the Company) in order
to adjust the number of shares of the common stock of the successor or acquiring corporation for which this Warrant is exercisable. For
purposes of this section, “common stock of the successor or acquiring corporation” shall include stock of such corporation of
any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject
to redemption and shall also include any evidences of indebtedness, shares of stock, or other securities which are convertible into or
exchangeable for any such stock, either immediately or upon the arrival of a specified date or the happening of a specified event and
any warrants or other rights to subscribe for or purchase any such stock. The foregoing provisions of this section shall similarly apply
to successive reorganizations, reclassifications, mergers, consolidations, or disposition of assets.

 

    2

     

    

 

7. If a voluntary or involuntary
dissolution, liquidation or winding up of the Company (other than in connection with a merger or consolidation of the Company) is at any
time proposed during the term of this Warrant, the Company shall give written notice to the Holder at least thirty days prior to the record
date of the proposed transaction. The notice shall contain: (1) the date on which the transaction is to take place; (2) the record date
(which must be at least thirty days after the giving of the notice) as of which holders of the Common Stock entitled to receive distributions
as a result of the transaction shall be determined; (3) a brief description of the transaction; (4) a brief description of the distributions,
if any, to be made to holders of the Common Stock as a result of the transaction; and (5) an estimate of the fair market value of the
distributions. On the date of the transaction, if it actually occurs, this Warrant and all rights existing under this Warrant shall terminate.

 

8. In no event shall any fractional
share of Common Stock of the Company be issued upon any exercise of this Warrant. If, upon exercise of this Warrant as an entirety, the
Holder would, except as provided in this Section 9, be entitled to receive a fractional share of Common Stock, then the Company shall
issue the next higher number of full Common Stock, issuing a full share with respect to such fractional share. If this Warrant is exercised
at one time for less than the maximum number of Common Stock purchasable upon the exercise hereof, the Company shall issue to the Holder
a new warrant of like tenor and date representing the number of Common Stock equal to the difference between the number of shares purchasable
upon full exercise of this Warrant and the number of shares that were purchased upon the exercise of this Warrant.

 

9. No adjustments in the Purchase
Price shall be required unless such adjustment would require an increase or decrease of at least one cent in such price, provided however,
that any adjustments which by reason of this Section 10 are not required to be made shall be carried forward and taken into account in
any subsequent adjustment.

 

10. Whenever the Purchase
Price is adjusted, as herein provided, the Company shall promptly deliver to the Holder a certificate setting forth the Purchase Price
after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

 

11. If at any time prior to
the expiration or exercise of this Warrant, the Company shall pay any dividend or make any distribution upon its Common Stock or shall
make any subdivision or combination of, or other change in its Common Stock (excluding, however, any forward or reverse stock split, stock
dividend, or similar transaction), the Company shall cause notice thereof to be provided to Holder at least ten full business days prior
to the record date set for determining the holders of Common Stock who shall participate in such dividend, distribution, subdivision,
combination or other change. Such notice shall also specify the record date as of which holders of Common Stock who shall participate
in such dividend or distribution is to be determined. Failure to give such notice, or any defect therein, shall not affect the legality
or validity of any dividend or distribution.

 

12. The Company will maintain
a register containing the names and addresses of the Holder and any assignees of this Warrant. Holder may change its address as shown
on the warrant register by written notice to the Company requesting such change. Any notice or written communication required or permitted
to be given to the Holder may be delivered by confirmed facsimile or telecopy or email or by a recognized overnight courier, addressed
to Holder at the address shown on the warrant register.

 

    3

     

    

 

13.  This Warrant and shares
underlying this Warrants have not been registered under the Securities Act of 1933, as amended (the “Securities Act”),
or any state securities laws (“State Acts”) or regulations in reliance upon exemptions under the Securities Act, and
exemptions under the State Acts. Subject to compliance with the Securities Act and State Acts, this Warrant and all rights hereunder are
transferable in whole or in part, at the office of the Company at which this Warrant is exercisable, upon surrender of this Warrant together
with the assignment hereof properly endorsed.

 

14.  In case this Warrant
shall be mutilated, lost, stolen, or destroyed, the Company may issue a new warrant of like tenor and denomination and deliver the same
(a) in exchange and substitution for and upon surrender and cancellation of any mutilated Warrant, or (b) in lieu of any Warrant lost,
stolen, or destroyed, upon receipt of evidence satisfactory to the Company of the loss, theft or destruction of such Warrant (including
a reasonably detailed affidavit with respect to the circumstances of any loss, theft, or destruction) and of indemnity with sufficient
surety satisfactory to the Company.

 

15. Unless a current registration
statement under the Securities Act, shall be in effect with respect to Common Stock to be issued upon exercise of this Warrant, the Holder,
by accepting this Warrant, covenants and agrees that, at the time of exercise hereof, and at the time of any proposed transfer of Common
Stock acquired upon exercise hereof, the Company may require Holder to make such representations, and may place such legends on certificates
representing Common Stock issuable upon exercise of this Warrant, as may be reasonably required in the opinion of counsel to the Company
to permit such Common Stock to be issued without such registration.

 

16.  This Warrant does not
entitle Holder to any of the rights of a stockholder of the Company.

 

17. Nothing expressed in this
Agreement and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give
to, any person or corporation other than the parties to this Agreement any covenant, condition, stipulation, promise, or agreement contained
herein, and all covenants, conditions, stipulations, promises and agreements contained herein shall be for the sole and exclusive benefit
of the parties hereto and their respective successors and assigns.

 

18. The provisions and terms of this Warrant shall be construed
in accordance with the laws of the State of Colorado.

 

[SIGNATURE PAGE FOLLOWS]

 

    4

     

    

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

	 	BESPOKE EXTRAACTS, INC.
	 	 
	 	By	 
	 	Name:  	Michael Feinsod
	 	Title: 	Chief Executive Officer

 

    5

     

    

 

EXHIBIT A

 

FORM OF EXERCISE

 

Date: ____________________

 

To: BESPOKE EXTRACTS, INC.

 

The undersigned hereby subscribes for _______ shares
of common stock of Bespoke Extracts., Inc. covered by this Warrant and hereby delivers $___________ in full payment of the purchase price
thereof. The certificate(s) for such shares should be issued in the name of the undersigned or as otherwise indicated below:

 

	 	
	 	Signature:
	 	 
	 	 
	 	Printed Name
	 	 
	 	 
	 	Name for Registration, if different
	 	 
	 	 
	 	Street Address
	 	 
	 	 
	 	City, State and Zip Code
	 	 
	 	 
	 	Social Security Number

 

     

     

    

 

EXHIBIT B

 

FORM OF ASSIGNMENT

 

For Value Received, the undersigned hereby sells,
assigns and transfers unto the assignee(s) set forth below the within Warrant certificate of Bespoke Extracts, Inc..; together with all
right, title and interest therein, and hereby irrevocably constitutes and appoints ___________________________________ attorney, to transfer
the said Warrant on the books of the within-named Company with respect to the number of Common Stock set forth below, with full power
of substitution in the premises.

 

	Name(s) of
    Assignee(s)	 	Social Security or

 other
    Identifying

 Number(s) of

 Assignee(s)	 	Address	 	No. of Shares
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 

 

Dated: ______________________________

 

	 	 
	 	Signature
	 	 
	 	NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE WARRANT IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT, OR ANY CHANGE WHATSOEVER.
	 	 
	 	 
	 	Print Name and Title

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]